BridgeMD
New treatment option for Speech
Official title Effects of Clear Speech on Listening Effort and Memory in Sentence Processing
ClinicalTrials.gov ID: NCT06053190
What this study is testing
- What it's testing
- Sensorineural hearing loss (SNHL) is among the most prevalent chronic conditions in aging and has a profoundly negative effect on speech comprehension, leading to increased social isolation, reduced quality of life, and increased risk for the development of dementia in older adulthood. Typical audiological tests and interventions, which focus on measuring and restoring audibility, do not explain the full range of cognitive difficulties that adults with hearing loss experience in speech comprehension.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 60 to 90. Healthy volunteers may be eligible.
You may be able to join if
- Age 60-90
- Right-handed
- Native English speaker
- Scores in the normal range (\> or = 25 points) on Montreal Cognitive Assessment (MoCA)
- For adults with hearing loss, a pure-tone average score of \> 25 dB HL (between 1 - 4kHz)
You likely can't join if
- Left-handed (language-related electrophysiological responses of left-handed people differ from those of right-handed people)
- History of psychiatric or neurological illnesses (including skull fractures, as this is known to alter electrophysiological response at the scalp)
- Score of \< 25 points on the MOCA
- Use of certain prescription and non-prescription drugs known to alter brain function and the autonomic nervous system, including pupil dilation...
- Any eye disease that would impair the ability to measure pupil dilation (e.g., cataracts, nystagmus, amblyopia)
- Scores on speech shadowing audibility control task below 50%, suggesting poor intelligibility
See the full eligibility criteria
- Age 60-90
- Right-handed
- Native English speaker
- Scores in the normal range (\> or = 25 points) on Montreal Cognitive Assessment (MoCA)
- For adults with hearing loss, a pure-tone average score of \> 25 dB HL (between 1 - 4kHz)
- Left-handed (language-related electrophysiological responses of left-handed people differ from those of right-handed people)
- History of psychiatric or neurological illnesses (including skull fractures, as this is known to alter electrophysiological response at the scalp)
- Score of \< 25 points on the MOCA
- Use of certain prescription and non-prescription drugs known to alter brain function and the autonomic nervous system, including pupil dilation (e.g., anti-depressants, attention deficit hyperactivity disorder drugs)
- Any eye disease that would impair the ability to measure pupil dilation (e.g., cataracts, nystagmus, amblyopia)
- Scores on speech shadowing audibility control task below 50%, suggesting poor intelligibility
- A display of behavior that would significantly interfere with the validity of data collection or safety during the study;
The study team makes the final eligibility decision.
Where it's taking place
- Salt Lake City, Utah, United States
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 60 years to 90 years. Healthy volunteers may be eligible. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Salt Lake City, Utah, United States. Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.